ArticleFrontiers in endocrinology2025
Risk factors of hypocalcemia after total thyroidectomy. A high volume center experience.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Prediction of early postoperative hypocalcemia and hypoparathyroidism after thyroidectomy for papillary thyroid carcinoma: dual-outcome prediction models.Frontiers in endocrinology · 2026Article
- Protection of parathyroid function during thyroid surgery with a complete intermediate approach: a retrospective multicenter observational study.BMC cancer · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Thyroidectomy is one of the most frequently performed surgical procedures worldwide. The most common complication of total thyroidectomy (TT) in the early postoperative period is hypocalcemia. This study aims to determine the risk factors for postoperative hypocalcemia after TT and to reveal their clinical value. As a secondary outcome, we assessed the effects of iatrogenic parathyroidectomy, surgical experience, and parathyroid transplantations on prolonged than one month hypocalcemia and intravenous calcium infusion requirement after TT. Methods: We designed our study as a retrospective cohort study. Two hundred sixty-three patients that underwent total thyroidectomy in a single tertiary endocrine surgery unit were included. Patients are followed up for 6 months. The study performed between April 2014 and March 2015. Patients were divided into two groups according to the presence or absence of hypocalcemia after surgery. All patients who performed total thyroidectomy without lymph node dissection in a single session were initially included in the study cohorts. Thereafter, patients with preoperatively confirmed hyperparathyroidism, hypoparathyroidism/hypocalcemia, had a history of thyroid operation, and postoperatively did not undergo regular follow-up (min. 12 months after surgery) were excluded from the latter analysis. Results: In the multivariate analysis we conducted in our study, we found that female gender, preoperative hyperthyroidism, intraoperative parathyroid autotransplantation, and surgical experience were independent risk factors. Some of them are predictable parameters such as surgeon experience and preoperative hyperthyroidism. Conclusions: We consider that specific theoretical and practical studies on thyroid surgery will reduce postoperative hypocalcemia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.